(2,4,5-trichlorophenoxy)acetic acid increases expression ISO RGD:1552377 6480464 2 more ... CTD PMID:18579281 1,1-dichloroethene decreases expression ISO RGD:1552377 6480464 vinylidene chloride results in decreased expression of SGK2 mRNA CTD PMID:26682919 1,2-dimethylhydrazine decreases expression ISO RGD:1552377 6480464 1, 2-Dimethylhydrazine results in decreased expression of SGK2 mRNA CTD PMID:22206623 17alpha-ethynylestradiol multiple interactions ISO RGD:1552377 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SGK2 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1552377 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SGK2 mRNA CTD PMID:17942748 2,4,6-trinitrotoluene affects expression EXP 6480464 Trinitrotoluene affects the expression of SGK2 mRNA CTD PMID:21346803 2-amino-4,6-dinitrotoluene affects expression EXP 6480464 2-amino-4, 6-dinitrotoluene affects the expression of SGK2 mRNA CTD PMID:21346803 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:20959002 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:1552377 6480464 tetrabromobisphenol A results in increased expression of SGK2 mRNA CTD PMID:25172293 4-hydroxyphenyl retinamide increases expression ISO RGD:1552377 6480464 Fenretinide results in increased expression of SGK2 mRNA CTD PMID:28973697 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of SGK2 mRNA CTD PMID:24780913 aflatoxin B1 affects expression ISO RGD:1347154 6480464 Aflatoxin B1 affects the expression of SGK2 protein CTD PMID:20106945 aflatoxin B1 increases expression ISO RGD:1347154 6480464 Aflatoxin B1 results in increased expression of SGK2 mRNA CTD PMID:21641981 aldehydo-D-glucose multiple interactions ISO RGD:1347154 6480464 SGK2 mutant form inhibits the reaction [[Simvastatin co-treated with NR1I2 protein] results in increased secretion of Glucose] CTD PMID:24204015 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of SGK2 mRNA CTD PMID:16483693 ampicillin decreases expression ISO RGD:1347154 6480464 Ampicillin results in decreased expression of SGK2 mRNA CTD PMID:21632981 aristolochic acid A increases expression ISO RGD:1347154 6480464 aristolochic acid I results in increased expression of SGK2 mRNA CTD PMID:33212167 arsane affects methylation ISO RGD:1347154 6480464 Arsenic affects the methylation of SGK2 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1347154 6480464 Arsenic affects the methylation of SGK2 gene CTD PMID:25304211 atorvastatin calcium multiple interactions ISO RGD:1347154 6480464 [Atorvastatin co-treated with NR1I2 protein] results in increased expression of SGK2 mRNA CTD PMID:24204015 azoxystrobin affects expression ISO RGD:1347154 6480464 azoxystrobin affects the expression of SGK2 mRNA CTD PMID:33512557 barium(0) multiple interactions ISO RGD:1347154 6480464 Barium inhibits the reaction [SGK2 protein results in increased transport of Potassium] CTD PMID:12590200 benzo[a]pyrene increases expression ISO RGD:1552377 6480464 Benzo(a)pyrene results in increased expression of SGK2 mRNA CTD PMID:19770486 , PMID:27195522 benzo[a]pyrene decreases expression ISO RGD:1347154 6480464 Benzo(a)pyrene results in decreased expression of SGK2 mRNA CTD PMID:32234424 benzo[a]pyrene increases methylation ISO RGD:1347154 6480464 Benzo(a)pyrene results in increased methylation of SGK2 3' UTR, Benzo(a)pyrene results in increased methylation of SGK2 5' UTR CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:1347154 6480464 Benzo(a)pyrene affects the methylation of SGK2 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1347154 6480464 Benzo(a)pyrene results in increased expression of SGK2 mRNA CTD PMID:20106945 more ... Benzo[ghi]perylene increases expression ISO RGD:1552377 6480464 1, 12-benzoperylene results in increased expression of SGK2 mRNA CTD PMID:26377693 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of SGK2 mRNA CTD PMID:18164116 beta-naphthoflavone increases expression ISO RGD:1347154 6480464 beta-Naphthoflavone results in increased expression of SGK2 mRNA CTD PMID:19737606 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1347154 6480464 Diethylhexyl Phthalate results in decreased expression of SGK2 mRNA CTD PMID:31163220 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SGK2 mRNA CTD PMID:25181051 bromobenzene decreases expression EXP 6480464 bromobenzene results in decreased expression of SGK2 mRNA CTD PMID:32479839 buta-1,3-diene decreases expression ISO RGD:1552377 6480464 1, 3-butadiene results in decreased expression of SGK2 mRNA CTD PMID:29038090 captan increases expression ISO RGD:1552377 6480464 Captan results in increased expression of SGK2 mRNA CTD PMID:31558096 carbon nanotube decreases expression ISO RGD:1552377 6480464 Nanotubes more ... CTD PMID:25620056 carbon nanotube increases expression ISO RGD:1552377 6480464 Nanotubes more ... CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:1347154 6480464 CGP 52608 promotes the reaction [RORA protein binds to SGK2 gene] CTD PMID:28238834 chromium(6+) affects expression ISO RGD:1552377 6480464 chromium hexavalent ion affects the expression of SGK2 mRNA CTD PMID:28472532 cisplatin increases expression ISO RGD:1347154 6480464 Cisplatin results in increased expression of SGK2 mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:1347154 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of SGK2 mRNA CTD PMID:27392435 clofibrate increases expression ISO RGD:1552377 6480464 Clofibrate results in increased expression of SGK2 mRNA CTD PMID:23811191 clothianidin decreases expression ISO RGD:1347154 6480464 clothianidin results in decreased expression of SGK2 mRNA CTD PMID:29044138 copper(II) sulfate increases expression ISO RGD:1347154 6480464 Copper Sulfate results in increased expression of SGK2 mRNA CTD PMID:19549813 copper(II) sulfate increases expression ISO RGD:1552377 6480464 Copper Sulfate results in increased expression of SGK2 mRNA CTD PMID:18579281 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of SGK2 mRNA CTD PMID:26577399 , PMID:27523638 cyclosporin A decreases expression ISO RGD:1347154 6480464 Cyclosporine results in decreased expression of SGK2 mRNA CTD PMID:20106945 cyclosporin A increases expression ISO RGD:1347154 6480464 Cyclosporine results in increased expression of SGK2 mRNA CTD PMID:27989131 D-glucose multiple interactions ISO RGD:1347154 6480464 SGK2 mutant form inhibits the reaction [[Simvastatin co-treated with NR1I2 protein] results in increased secretion of Glucose] CTD PMID:24204015 dextran sulfate multiple interactions ISO RGD:1552377 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SGK2 mRNA CTD PMID:29950665 dichloroacetic acid increases expression ISO RGD:1552377 6480464 Dichloroacetic Acid results in increased expression of SGK2 mRNA CTD PMID:28962523 diclofenac decreases expression ISO RGD:1552377 6480464 Diclofenac results in decreased expression of SGK2 mRNA CTD PMID:26934552 dicrotophos increases expression ISO RGD:1347154 6480464 dicrotophos results in increased expression of SGK2 mRNA CTD PMID:28302478 dioxygen increases expression ISO RGD:1347154 6480464 Oxygen deficiency results in increased expression of SGK2 mRNA CTD PMID:26516004 dorsomorphin multiple interactions ISO RGD:1347154 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SGK2 mRNA CTD PMID:27188386 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of SGK2 mRNA CTD PMID:29391264 fenofibrate increases expression ISO RGD:1347154 6480464 Fenofibrate results in increased expression of SGK2 mRNA CTD PMID:25572481 fluvastatin multiple interactions ISO RGD:1347154 6480464 [fluvastatin co-treated with NR1I2 protein] results in increased expression of SGK2 mRNA CTD PMID:24204015 glucose multiple interactions ISO RGD:1347154 6480464 SGK2 mutant form inhibits the reaction [[Simvastatin co-treated with NR1I2 protein] results in increased secretion of Glucose] CTD PMID:24204015 glutathione increases expression EXP 6480464 Glutathione deficiency results in increased expression of SGK2 mRNA CTD PMID:20621112 GW 4064 increases expression ISO RGD:1552377 6480464 GW 4064 results in increased expression of SGK2 mRNA CTD PMID:26655953 hydrogen peroxide affects expression ISO RGD:1347154 6480464 Hydrogen Peroxide affects the expression of SGK2 mRNA CTD PMID:23410634 isotretinoin decreases expression ISO RGD:1347154 6480464 Isotretinoin results in decreased expression of SGK2 mRNA CTD PMID:20436886 Licochalcone B increases expression ISO RGD:1347154 6480464 licochalcone B results in increased expression of SGK2 mRNA CTD PMID:33647349 menadione affects expression ISO RGD:1347154 6480464 Vitamin K 3 affects the expression of SGK2 mRNA CTD PMID:23410634 metformin increases expression EXP 6480464 Metformin results in increased expression of SGK2 mRNA CTD PMID:31324951 methylmercury chloride decreases expression ISO RGD:1347154 6480464 methylmercuric chloride results in decreased expression of SGK2 mRNA CTD PMID:29581082 N-methylformamide increases expression ISO RGD:1552377 6480464 methylformamide analog results in increased expression of SGK2 mRNA, methylformamide results in increased expression of SGK2 mRNA CTD PMID:17040096 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of SGK2 mRNA CTD PMID:18164116 nickel atom decreases expression ISO RGD:1347154 6480464 Nickel results in decreased expression of SGK2 mRNA CTD PMID:24768652 , PMID:25583101 ouabain multiple interactions ISO RGD:1347154 6480464 Ouabain inhibits the reaction [SGK2 protein results in increased transport of Potassium] CTD PMID:12590200 paracetamol affects expression ISO RGD:1552377 6480464 Acetaminophen affects the expression of SGK2 mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of SGK2 mRNA CTD PMID:32479839 paracetamol decreases expression ISO RGD:1347154 6480464 Acetaminophen results in decreased expression of SGK2 mRNA CTD PMID:21420995 , PMID:29067470 paraquat increases expression EXP 6480464 Paraquat results in increased expression of SGK2 mRNA CTD PMID:32680482 paraquat decreases expression ISO RGD:1347154 6480464 Paraquat results in decreased expression of SGK2 mRNA CTD PMID:35182771 PCB138 decreases expression EXP 6480464 2 more ... CTD PMID:23829299 phenobarbital increases expression ISO RGD:1347154 6480464 Phenobarbital results in increased expression of SGK2 mRNA CTD PMID:19084549 picoxystrobin decreases expression ISO RGD:1347154 6480464 picoxystrobin results in decreased expression of SGK2 mRNA CTD PMID:33512557 pirinixic acid increases expression ISO RGD:1552377 6480464 pirinixic acid results in increased expression of SGK2 mRNA CTD PMID:17426115 more ... potassium atom multiple interactions ISO RGD:1347154 6480464 Barium inhibits the reaction [SGK2 protein results in increased transport of Potassium], Ouabain inhibits the reaction [SGK2 protein results in increased transport of Potassium] CTD PMID:12590200 potassium atom increases transport ISO RGD:1347154 6480464 SGK2 protein results in increased transport of Potassium CTD PMID:12590200 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:1552377 6480464 Pregnenolone Carbonitrile results in decreased expression of SGK2 mRNA CTD PMID:28903501 propiconazole decreases expression ISO RGD:1552377 6480464 propiconazole results in decreased expression of SGK2 mRNA CTD PMID:21278054 quinolin-8-ol decreases expression ISO RGD:1347154 6480464 Oxyquinoline results in decreased expression of SGK2 mRNA CTD PMID:21632981 rifampicin increases expression ISO RGD:1347154 6480464 Rifampin results in increased expression of SGK2 mRNA CTD PMID:24204015 rifampicin multiple interactions ISO RGD:1347154 6480464 [Rifampin co-treated with NR1I2 protein] results in increased expression of SGK2 mRNA more ... CTD PMID:21127053 , PMID:24204015 rotenone decreases expression ISO RGD:1347154 6480464 Rotenone results in decreased expression of SGK2 mRNA CTD PMID:33512557 SB 431542 multiple interactions ISO RGD:1347154 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SGK2 mRNA CTD PMID:27188386 silicon dioxide affects expression ISO RGD:1347154 6480464 Silicon Dioxide analog affects the expression of SGK2 mRNA CTD PMID:25895662 simvastatin multiple interactions ISO RGD:1347154 6480464 [Simvastatin co-treated with NR1I2 protein] results in increased expression of SGK2 mRNA more ... CTD PMID:24204015 sodium arsenite increases expression ISO RGD:1347154 6480464 sodium arsenite results in increased expression of SGK2 mRNA CTD PMID:29301061 sodium arsenite decreases expression ISO RGD:1347154 6480464 sodium arsenite results in decreased expression of SGK2 mRNA CTD PMID:34032870 streptozocin increases expression ISO RGD:1552377 6480464 Streptozocin results in increased expression of SGK2 mRNA CTD PMID:16116964 tert-butyl hydroperoxide affects expression ISO RGD:1347154 6480464 tert-Butylhydroperoxide affects the expression of SGK2 mRNA CTD PMID:23410634 tetrachloroethene increases expression ISO RGD:1552377 6480464 Tetrachloroethylene results in increased expression of SGK2 mRNA CTD PMID:28973375 tetrachloromethane decreases expression ISO RGD:1552377 6480464 Carbon Tetrachloride results in decreased expression of SGK2 mRNA CTD PMID:31919559 titanium dioxide multiple interactions ISO RGD:1552377 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SGK2 mRNA CTD PMID:29950665 tremolite asbestos increases expression ISO RGD:1552377 6480464 tremolite results in increased expression of SGK2 mRNA CTD PMID:29279043 troglitazone increases expression ISO RGD:1552377 6480464 troglitazone results in increased expression of SGK2 mRNA CTD PMID:28973697 troglitazone increases expression ISO RGD:1347154 6480464 troglitazone results in increased expression of SGK2 mRNA CTD PMID:25572481 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of SGK2 mRNA CTD PMID:21515302 urethane decreases expression ISO RGD:1347154 6480464 Urethane results in decreased expression of SGK2 mRNA CTD PMID:28818685 valproic acid increases expression ISO RGD:1347154 6480464 Valproic Acid results in increased expression of SGK2 mRNA CTD PMID:29154799 valproic acid multiple interactions ISO RGD:1347154 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SGK2 mRNA CTD PMID:27188386 valproic acid decreases expression ISO RGD:1347154 6480464 Valproic Acid results in decreased expression of SGK2 mRNA CTD PMID:24383497 , PMID:26272509 vancomycin increases expression ISO RGD:1552377 6480464 Vancomycin results in increased expression of SGK2 mRNA CTD PMID:18930951